1. Início
  2. Hospital das Clínicas da Faculdade de Medicina - HC
  3. Instituto Central - HC/ICHC
  4. Comunicações em Eventos - HC/ICHC
Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/36468
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSANDS, B. E.
dc.contributor.authorTAUB, P. R.
dc.contributor.authorFEAGAN, B. G.
dc.contributor.authorARMUZZI, A.
dc.contributor.authorDAMIAO, A. O.
dc.contributor.authorLAWENDY, N.
dc.contributor.authorSOLANO, G.
dc.contributor.authorKWOK, K.
dc.contributor.authorWOOLCOTT, J.
dc.contributor.authorSALESE, L.
dc.contributor.authorSU, C.
dc.date.accessioned2020-06-17T11:46:22Z-
dc.date.available2020-06-17T11:46:22Z-
dc.date.issued2020
dc.identifier.citationJOURNAL OF CROHNS & COLITIS, v.14, suppl.1, p.S557-S558, 2020
dc.identifier.issn1873-9946
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/36468-
dc.language.isoeng
dc.publisherOXFORD UNIV PRESSeng
dc.relation.ispartofJournal of Crohns & Colitis
dc.rightsrestrictedAccesseng
dc.titleThe effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: updated results from the tofacitinib ulcerative colitis clinical programmeeng
dc.typeconferenceObjecteng
dc.rights.holderCopyright OXFORD UNIV PRESSeng
dc.subject.wosGastroenterology & Hepatologyeng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalSANDS, B. E.:Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
hcfmusp.author.externalTAUB, P. R.:Univ Calif San Diego, Sch Med, Div Cardiovasc Med, La Jolla, CA USA
hcfmusp.author.externalFEAGAN, B. G.:Western Univ, Robarts Clin Trials, London, ON, Canada
hcfmusp.author.externalARMUZZI, A.:Univ Cattolica Sacro Cuore, Fdn Policlin Univ Gemelli IRCCS, IBD Unit, Rome, Italy
hcfmusp.author.externalLAWENDY, N.:Pfizer Inc, Collegeville, PA USA
hcfmusp.author.externalSOLANO, G.:Pfizer Inc, San Jose, Costa Rica
hcfmusp.author.externalKWOK, K.:Pfizer Inc, New York, NY USA
hcfmusp.author.externalWOOLCOTT, J.:Pfizer Inc, Collegeville, PA USA
hcfmusp.author.externalSALESE, L.:Pfizer Inc, Collegeville, PA USA
hcfmusp.author.externalSU, C.:Pfizer Inc, Collegeville, PA USA
hcfmusp.description.beginpageS557
hcfmusp.description.endpageS558
hcfmusp.description.issuesuppl 1
hcfmusp.description.volume14
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000518803402267
hcfmusp.publisher.cityOXFORDeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceSands BE, 2019, CLIN GASTROENTEROL Heng
dc.description.indexMEDLINEeng
dc.identifier.eissn1876-4479
Appears in Collections:

Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC


Files in This Item:
There are no files associated with this item.
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.